菜单
Valuation criteria for emerging market insurance stocks. P/B 0.5-1.0x with 30-50% EM discount, combined ratio targets, and China vs India market comparisons.
默认使用会先检查来源的 Prompt；你也可以切换为直接命令，或下载本地副本。
决定是否安装前，请先阅读 SKILL.md，以及 SkillsMP 当前展示的配套文件。
基于 SOC 职业分类
用 Codex 或 Claude 帮你安装 复制这段 Prompt，粘贴到 Codex、Claude 或其他助手里，让它检查 Skill 页面并帮你完成安装。
直接命令不会经过审查 Prompt；运行前请先检查来源。
npx skills add https://github.com/FDU-INS/Insurance-Skills --skill insurance-emerging-value命令会保持在同一行。复制前请横向滚动并检查完整内容。
想先保存到本地？可下载 SkillsMP 当前能够提供的文件。
正在显示 SKILL.md
Complete architecture reference for the A3 insurance platform — file locations, data flow, conventions, microservice map, and fullstack patterns
Drafts U.S. commercial real estate access and indemnity (right-of-entry) agreements for pre-closing due diligence. Covers license grants, non-invasive vs invasive testing gates, insurance/endorsement requirements, indemnity with discovery carve-outs, restoration and lien remedies, confidentiality, and anti-indemnity guardrails. Trigger: access agreement, right of entry, due diligence access, Phase I/II, invasive testing, pre-PSA site inspection.
Guide actuarial analysis for insurance pricing. TRIGGERS - Use when user needs help with actuarial-analysis related tasks.
| name | insurance-emerging-value |
| description | Valuation criteria for emerging market insurance stocks. P/B 0.5-1.0x with 30-50% EM discount, combined ratio targets, and China vs India market comparisons. |
| metadata | {"sector":"insurance","market":"emerging","stock_type":"value"} |
Method: P/B + Combined Ratio + Market Penetration Analysis
| Metric | Target | EM Consideration |
|---|---|---|
| P/B Ratio | 0.5-1.0x | 30-50% lower than developed markets |
| Combined Ratio | <95% | Higher acceptable ratio; growing market, margin compression normal |
| Premium Growth | 15%+ YoY | Penetration of underinsured population |
| Expense Ratio | <35% | Higher than developed (still building distribution) |
| Regulatory Capital | Solvency II equivalent | Varies by country; India: IRDAI requirements |